Unilever PLC ULVR.L
GB · London Stock Exchange · XLON · stock · Consumer Defensive · website
Unilever PLC financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €50.5B | €52.5B | €51.7B | €60.1B |
| Gross profit | €23.7B | €24.5B | €22.5B | €24.2B |
| R&D expense | — | €987.0M | €949.0M | €908.0M |
| SG&A expense | €13.7B | €14.3B | €13.3B | €13.6B |
| Operating income | €10.1B | €10.3B | €9.3B | €9.7B |
| Interest expense | €1.1B | €999.0M | €955.0M | €789.0M |
| Income tax | €2.5B | €2.3B | €2.0B | €2.1B |
| Net income | €9.5B | €5.7B | €6.5B | €7.6B |
| EPS (diluted) | €4.32 | €2.58 | €2.88 | €3.36 |
| Operating cash flow | €8.3B | €9.5B | €9.4B | €7.3B |
| Free cash flow | €6.8B | €7.9B | €8.0B | €5.6B |
| Cash & equivalents | €3.9B | €6.1B | €4.2B | €4.3B |
| Inventory | €4.0B | €5.2B | €5.1B | €5.9B |
| Goodwill | €17.7B | €22.3B | €21.1B | €21.6B |
| Total assets | €70.5B | €79.8B | €75.3B | €77.8B |
| Total debt | €27.6B | €30.7B | €28.6B | €28.4B |
| Total liabilities | €52.9B | €57.2B | €54.5B | €56.1B |
| Shareholders' equity | €15.5B | €20.0B | €18.1B | €19.0B |
| Share buybacks | €1.5B | €1.5B | €1.5B | €1.5B |
Growth · year-over-year · Revenue CAGR -5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -3.8% | +1.5% | -14.0% | — |
| Net income growth | +64.9% | -11.5% | -15.1% | — |
| EPS growth | +67.7% | -10.5% | -14.4% | — |
| Free cash flow growth | -14.5% | -1.1% | +43.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · GB · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.